Intranasal tumors in dogs are rare neoplastic diseases with obvious clinical signs, such as epistaxis, nasal congestion, and facial deformity. Radiation therapy is the treatment of choice but is not always accessible due to geographical location, logistics, or financial constraints. Other treatments may not be used because of various restrictions. We performed transnasal intranasal tumor volume reduction in 2 dogs with intranasal tumors; 1 dog had an adenocarcinoma and the other had a fibrosarcoma. In both cases, improvement in the quality of life (QOL), including reduced clinical signs and increased activity, was observed ~1 wk after treatment. No obvious complications were associated with this treatment. Although tumor recurrence was noted in both cases, this treatment could be applied multiple times. In conclusion, transnasal nasal tumor volume reduction is a palliative method that contributes to improvement of clinical signs and QOL. Key clinical message: We report palliative treatment of intranasal tumors in dogs. The treatment described in this report is available to most veterinarians and helps improve the QOL of dogs with nasal tumors, including improving respiratory status.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891793 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Usefulness of transnasal volume-reduction treatment for nasal tumors by ultrasonic emulsification suction in 2 dogs.
Can Vet J
March 2025
Faculty of Veterinary Medicine, Okayama University of Science, 1-3 Ikoinooka, Imabari, Ehime 794-8555, Japan (Mizutani S, Asanuma); University of Miyazaki Veterinary Teaching Hospital, 1-1 Gakuen Kibana-dai Nishi, Miyazaki, Miyazaki 889-2192, Japan (Mizutani Y); Okayama University of Science Veterinary Medical Teaching Hospital, 1-3 Ikoinooka, Imabari, Ehime 794-8555, Japan (Goda); Laboratory of Companion Animal Surgery, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido 069-8501, Japan (Torisu).
Intranasal tumors in dogs are rare neoplastic diseases with obvious clinical signs, such as epistaxis, nasal congestion, and facial deformity. Radiation therapy is the treatment of choice but is not always accessible due to geographical location, logistics, or financial constraints. Other treatments may not be used because of various restrictions.
View Article and Find Full Text PDFMesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1/PD-L1 interaction.
J Nanobiotechnology
March 2025
Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin, 150081, China.
Neuroinflammation triggered by microglia activation is hallmark of autism spectrum disorder (ASD), and this process includes crucial metabolic reprogramming from oxidative phosphorylation to glycolysis, which may cause neuron loss and functional impairment. The inhibitory immune checkpoint programmed cell death protein 1 (PD-1) on immune cells is an important target for tumor immunotherapy. However, the immunomodulatory effects of PD-1 in ASD remains to be elusive.
View Article and Find Full Text PDFExploring the impact of ambient air PM on multiple sclerosis: an experimental dive into neuroinflammation.
Toxicol Mech Methods
March 2025
Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran.
There is mounting evidence about the connection between particulate matter (PM) and neuroinflammation. This study aimed to evaluate the toxicological effects of PM associated with inflammatory factors in a mouse's multiple sclerosis (MS) model. Thirty C57BL/6 male mice were categorized into five groups: a group of healthy mice, a control cuprizone-induced MS group, and three MS-induced groups, intranasally exposed to three concentrations of ambient air PM (5, 10, and 20 mg/mL) from Tehran in a phosphate-buffered saline (PBS) solution.
View Article and Find Full Text PDFSafety, Efficacy and Bio-Distribution Analysis of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells for Effective Treatment of Bronchopulmonary Dysplasia by Intranasal Administration in Mice Model.
Int J Nanomedicine
March 2025
Division of Neonatology, Department of Pediatrics, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China.
Purpose: Exosomes (Exos) derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) hold great potential for treating bronchopulmonary dysplasia (BPD); however, safety concerns and effects of intranasal administration remain unexplored. This study aimed to explore the safety of hUC-MSCs and Exos and to investigate the efficacy and bio-distribution of repeated intranasal Exos administration in neonatal BPD models.
Methods: Characteristics of hUC-MSCs and Exos were analyzed.
Intranasal delivery of AEP inhibitor-loaded neuron-targeted liposome ameliorates radiation-induced brain injury.
Mater Today Bio
April 2025
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Acute exposure to high-dose radiation during head and neck tumors radiotherapy can result in radiation-induced brain injury (RIBI), characterized by neurocognitive deficits, dementia, and epilepsy. Asparagine endopeptidase (AEP), a cysteine proteinase, is effective in preventing neurodegenerative diseases and RIBI. However, the limited permeability of selective AEP inhibitor (AEPI) delivery to the brain reduces its effectiveness in preventing RIBI.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!